Skip to main content

Year: 2023

Interim consolidated financial statement of Grigeo AB covering 9 months of 2023

Over 9 months of 2023, Grigeo AB company group (hereinafter – the Group), consisting of Grigeo AB, Grigeo Packaging UAB, Grigeo Baltwood UAB, Grigeo Klaipėda AB, Mena Pak AT, Grigeo Recycling UAB, Grigeo Recycling SIA and Grigeo investicijų valdymas UAB achieved the consolidated sales turnover of EUR 149.4 million. It is by EUR 3.1 million less than over respective period of 2022. Over the reporting period, the Group earned EUR 24.1 million profit before taxes, which is by EUR 17.1 million more than in the same period in 2022. Earnings before interest, taxes, depreciation, and amortization (EBITDA) of the Group, if compared with 9 months of 2022, increased by EUR 17.0 million and reached EUR 31.1 million. The following table summarizes 9-month performance numbers stated in this announcement:Indicator, EUR million 2023 2022 Change...

Continue reading

Addex Therapeutics to Release Third Quarter 2023 Financial Results and Host Conference Call on November 29, 2023

Geneva, Switzerland, November 23, 2023 – Addex Therapeutics (SIX and Nasdaq: ADXN), a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development, today announced that that it will issue its Third Quarter 2023 Financial Results on November 29, 2023. Tim Dyer, CEO , Robert Lütjens, Head of Discovery – Biology and Mikhail Kalinichev, Head of Translational Science, will provide a business update and a review of the Addex product pipeline during a teleconference and webcast for investors, analysts and media at 16:00 CET (15:00 GMT / 10:00 EST / 07:00 PST) the same day. Title:   Addex Therapeutics to Release Third Quarter 2023 Financial Results and Provides Corporate Update Date:   November 29, 2023Time: 16:00 CET (15:00 GMT / 10:00 EST / 07:00 PST) Joining the Conference Call:Participants...

Continue reading

Vow ASA: Invitation to Capital Markets Update 28 November 2023

Vow ASA (OSE: VOW) is pleased to confirm and invite shareholders, investors, analysts, and other interested parties to its Capital Markets Update on 28 November 2023. The sessions will be streamed. Attendance in person is welcome. Where: Haakon VIIs gate 2 in OsloWhen: 28 November 2023 from 09:00 to 10:30 CET. From the agenda:– Q3 trading update – Business deep dive– Outlook Henrik Badin, Chief Executive Officer of Vow, will host the session. Other speakers include Chief Financial Officer Tina Tønnessen and other representatives from company management and business partners. The presentation material will be published on NewsWeb and on Vow web site that same morning. The session will be held in English. To register and follow the presentation online, please copy and paste the following link into your browser, click Attend...

Continue reading

SIKA EXPANDS PRODUCTION CAPACITY FOR CONCRETE ADMIXTURES IN THE USA

SIKA EXPANDS PRODUCTION CAPACITY FOR CONCRETE ADMIXTURES IN THE USA Sika continues to invest in its polymer production at its Sealy site in the US state of Texas, Sika’s latest move marks its second polymer investment in the state of Texas in just five years. Polymers are chemical building blocks needed to manufacture Sika® ViscoCrete®, Sika’s high-performance, resource-saving concrete admixture. The company has initiated this expansion due to the rising demand for its concrete admixture in the USA and Canada. In the upcoming years, U.S. government initiatives, such as the Infrastructure Investment and Jobs Act (IIJA) and the Inflation Reduction Act (IRA), will unlock numerous business opportunities for a broad range of Sika solutions. With goals to revitalize America’s infrastructure and address climate change, there will be increased...

Continue reading

Ackermans & van Haaren: Well on track to post a solid set of results for the full year 2023

Dear shareholder, Dear Madam, Dear Sir,The board of directors confirms that Ackermans & van Haaren is well on track to post a solid set of results for the full year 2023. The contribution from core segments of the group is expected to further improve on the record level of 354.4 million euros of 2022. Please find attached our trading update on the third quarter 2023.Best regards Ackermans & van HaarenAttachmentAvH press release

Continue reading

Junshi Biosciences Announces Lancet Infectious Diseases Publication of Results from the 2nd Phase 3 Study of VV116 for Treating COVID-19

SHANGHAI, China, Nov. 22, 2023 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences,” HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced a new publication in the Lancet Infectious Diseases. The paper presents final analysis results from a multicenter, double-blind, phase 3, randomized controlled study (NCT05582629) evaluating the efficacy and safety of VV116 (mindeudesivir hydrobromide tablets, product code: VV116/JT001) in patients with mild-to-moderate COVID-19. This study demonstrated that VV116 significantly reduced the time to sustained clinical symptom resolution compared to placebo, with no observed safety concerns. During the study, academician Lanjuan LI, Director of the State...

Continue reading

PubMatic and PhonePe Partner to Deliver High Quality and Engaging Audience Assets to Advertisers in India

NEW DELHI, India, Nov. 22, 2023 (GLOBE NEWSWIRE) — PubMatic (Nasdaq: PUBM), an independent technology company delivering digital advertising’s supply chain of the future, announced its partnership today with PhonePe, India’s leading mobile payments and financial services platform. This strategic collaboration makes PhonePe’s premium mobile app inventory and audiences available to PubMatic’s programmatic buying partners. As the industry looks for sustainable and differentiated solutions, this partnership provides Indian media buyers with a unique opportunity to tap into PhonePe’s Indic-language-speaking audiences across a diverse range of metropolitan and non-metropolitan locations. With 500+ million registered users and over 47% market share in India’s Unified Payments Interface (UPI) instant payments ecosystem, PhonePe plays a...

Continue reading

LexinFintech Holdings Ltd. Reports Third Quarter 2023 Unaudited Financial Results

Vintage Charge Off CurveVintage Charge Off CurveDpd30+/GMV by Performance WindowsDpd30+/GMV by Performance WindowsFirst Payment Default 30+First Payment Default 30+SHENZHEN, China, Nov. 22, 2023 (GLOBE NEWSWIRE) — LexinFintech Holdings Ltd. (“Lexin” or the “Company”) (NASDAQ: LX), a leading technology-empowered personal financial service enabler in China, today announced its unaudited financial results for the quarter ended September 30, 2023. “Lexin reported total loan originations of RMB63.3 billion for the third quarter of 2023, achieving a year-over-year increase of 12.7%. Cumulatively, our growth for the first three quarters stands at 26.7%. The outstanding loan balance reached RMB121 billion, reflecting an increase of 27.7% compared to last year,” said Jay Wenjie Xiao, Chairman and CEO of Lexin....

Continue reading

Bird Continues To Grow Institutional & Nuclear Portfolio In Ontario

MISSISSAUGA, Ontario, Nov. 22, 2023 (GLOBE NEWSWIRE) — Bird Construction Inc. (TSX:BDT) is pleased to announce that it has been awarded a construction management contract for the Seneca Polytechnic Health & Wellness Centre Project (“the Seneca Health & Wellness Centre”) and a new multi-year task order under the previously announced Port Hope Area Initiative (“PHAI”) Master Construction Contract (“MCC”) by Canadian Nuclear Laboratories (“CNL”). The value of the awards exceeds $130 million. A dynamic multi-storey health and wellness complex, the Seneca Health & Wellness Centre will be a destination for students and employees to support their physical, mental, emotional, and spiritual wellness. In alignment with Seneca’s commitment to sustainability, many green practices will be incorporated, including mass...

Continue reading

Canadian Net REIT Announces 2023 Third-Quarter Results

– REIT also announces monthly distributions for Q1 2024 – MONTRÉAL, Nov. 22, 2023 (GLOBE NEWSWIRE) — Canadian Net Real Estate Investment Trust (“Canadian Net” or the “REIT”) (TSX-V: NET.UN) today reported its results for the quarter ended September 30th, 2023 (“Q3 2023”). The REIT also announced distributions for the months of January, February and March 2024.  “We are pleased with the performance of our portfolio. As of September 30, 2023, we maintained full occupancy at 100%, and our payout ratio remained at 55%,” said Kevin Henley, President and CEO. “CNET is well-positioned with its tenant base consisting primarily of essential national retailers and our outlook remains positive. So far this year, we successfully divested three properties at valuations higher than our IFRS values, including a property in Trois-Rivières...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.